Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 08-2009 | 05-2009 | 02-2009 | 11-2008 | 08-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 95 | 266 | 21 | 40 | 15 |
| TOTAL | $110 | $273 | $29 | $67 | $54 |
| Non-Current Assets | |||||
| PPE Net | 4 | 2 | 2 | 3 | 1 |
| Intangibles | 0 | 0 | 0 | 0 | 1 |
| Other Non-Current Assets | 28 | 30 | 32 | 33 | 35 |
| TOTAL | $31 | $32 | $34 | $37 | $37 |
| Total Assets | $142 | $305 | $63 | $104 | $91 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 40 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 295 | 350 | 418 | 417 | 376 |
| Accrued Expenses | 34 | 49 | 49 | 74 | 124 |
| Other current liabilities | N/A | 25 | N/A | N/A | N/A |
| TOTAL | $396 | $492 | $467 | $492 | $500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 151 | 262 | 669 | 676 | 685 |
| Other Non-Current Liabilities | 236 | 251 | 250 | 250 | 251 |
| TOTAL | $387 | $513 | $919 | $952 | $960 |
| Total Liabilities | $784 | $1,005 | $1,386 | $1,443 | $1,460 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,891 | 19,891 | 19,891 | 20,091 | 20,091 |
| Common Shares | 6,718 | 6,286 | 5,675 | 5,466 | 4,863 |
| Retained earnings | -10,471 | -10,148 | -10,075 | -9,792 | -9,134 |
| Other shareholders' equity | 0 | 167 | 0 | 0 | 0 |
| TOTAL | $-642 | $-700 | $-1,323 | $-1,339 | $-1,369 |
| Total Liabilities And Equity | $142 | $305 | $63 | $104 | $91 |